PCK

3.45%

3.0¢ painchek ltd

Don't know Painchek after 5 years...

First 47 Last

Share
Profile

Follow
AlCp

27,886 Posts.

1795

02/08/24

19:10

Post #: 75050895
Share
Originally posted by Gerrick ↑

The PCK Universal App consists on two core features:

The PainChek tool – to assess pain for those who cannot verbalise reliably

The Numeric Rating Scale (NRS) tool – to document the pain for those who can self-report.

The combination of these two tools in one App makes PainChek “universal” i.e. able to document the pain levels for all people. Both tools are validated for use with these resident or patient types.

The PainChek App is primarily licenced for use in Aged Care because that’s where most people who cannot verbalise reliably reside e.g. dementia - and because that’s where we started.

It’s well documented that approx 30% of hospital beds are now occupied by people living with dementia. There are dementia wards and geriatric wards springing up everywhere. These wards and other areas in the hospital (e.g. post-surgery) and ideal for PainChek Universal.

We have a small number of PainChek hospital contracts to date – specifically for use in these types of wards – and are looking to expand more broadly and in discussions with Ramsey group in Australia and Edinburgh Royal Infirmary in Scotland amongst others. Its new sector for us – but it’s the same product for people with the same conditions.

Most doctors or nurses in hospitals would not know of PainChek ….yet.

Finally, we don’t have the data or evidence around “drug seeking behaviour” I assume that means Opioids? But we are building more evidence that we reduce the risk of mismedication such as inappropriate use of anti-psychotics and benzodiazepines for people living with dementia. See the Orchard care publications.

Hope that helps the conversation. Let me know you need anything else.

Expand

Don't know Painchek after 5 years commercialisation........that's tells you something.
PCK Price at posting: 3.4¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

First 47 Last

Add PCK (ASX) to my watchlist

(20min delay)
Last 3.0¢		Change 0.001(3.45%)		Mkt cap ! $49.11M

Open	High	Low	Value	Volume
2.9¢	3.0¢	2.9¢	$16.16K	553.1K

Buyers (Bids)

No.	Vol.	Price($)
1	41868	2.9¢

Sellers (Offers)

Price($)	Vol.	No.
3.0¢	354462	2

View Market Depth

No.	Vol.	Price($)
1	41868	0.029
4	858114	0.028
5	874074	0.027
6	1463115	0.026
5	1239601	0.025

Price($)	Vol.	No.
0.030	354462	2
0.031	350000	2
0.032	421538	2
0.033	100000	1
0.034	108791	1

Last trade - 16.10pm 15/11/2024 (20 minute delay)

PCK (ASX) Chart

Don't know Painchek after 5 years...

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Cyclone signs MOU with Vale for development of Iron Bear play

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Banshee's historic trenches prove rich in antimony and gold for GDM

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Don't know Painchek after 5 years...

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Cyclone signs MOU with Vale for development of Iron Bear play

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Banshee's historic trenches prove rich in antimony and gold for GDM

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News